Borman Andrew M, Fraser Mark, Patterson Zoe, Linton Christopher J, Palmer Michael, Johnson Elizabeth M
UK Health Security Agency National Mycology Reference Laboratory, Southmead Hospital, Bristol BS10 5NB, UK.
Medical Research Council Centre for Medical Mycology, University of Exeter, Exeter EX4 4QD, UK.
J Fungi (Basel). 2022 Mar 25;8(4):343. doi: 10.3390/jof8040343.
Subcutaneous fungal infections, which typically result from traumatic introduction (implantation) of fungal elements into the skin or underlying tissues, can present as a range of different clinical entities including phaeohyphomycosis, chromoblastomycosis, subcutaneous nodules or masses, and genuine eumycetoma. Here, we mined our laboratory information management system for such infections in humans and domestic animals for the period 2016-2022, including (i) fungal isolates referred for identification and/or susceptibility testing; (ii) infections diagnosed at our laboratory using panfungal PCR approaches on infected tissue; and (iii) organisms cultured in our laboratory from biopsies. In total, 106 cases were retrieved, involving 39 fungal species comprising 26 distinct genera. Subcutaneous infections with species were the most frequent (36 cases), which possibly reflects the ubiquitous nature of this common plant pathogen. A substantial proportion of spp. isolates exhibited reduced in vitro susceptibility to voriconazole. Notably, a significant number of subcutaneous infections were diagnosed in renal and other solid organ transplant recipients post transplantation, suggesting that humans may harbour "inert" subcutaneous fungal elements from historical minor injuries that present as clinical infections upon later immunosuppression. The current study underscores the diversity of fungi that can cause subcutaneous infections. While most organisms catalogued here were responsible for occasional infections, several genera () were more frequently recovered in our searches, suggesting that they possess virulence factors that facilitate subcutaneous infections and/or inhabit natural niches that make them more likely to be traumatically inoculated.
皮下真菌感染通常是由于真菌成分经创伤性途径(植入)进入皮肤或皮下组织所致,可表现为一系列不同的临床病症,包括暗色丝孢霉病、着色芽生菌病、皮下结节或肿块以及真性真菌瘤。在此,我们在实验室信息管理系统中检索了2016年至2022年期间人类和家畜的此类感染情况,包括:(i)送检进行鉴定和/或药敏试验的真菌分离株;(ii)在我们实验室使用泛真菌PCR方法对感染组织进行诊断的感染病例;以及(iii)在我们实验室从活检组织中培养出的微生物。总共检索到106例病例,涉及39种真菌,分属于26个不同的属。[具体真菌名称]感染最为常见(36例),这可能反映了这种常见植物病原体的广泛存在。相当一部分[具体真菌名称]分离株对伏立康唑的体外敏感性降低。值得注意的是,大量皮下感染病例是在肾移植和其他实体器官移植受者移植后诊断出来的,这表明人类可能携带来自既往轻微损伤的“潜伏”皮下真菌成分,在后期免疫抑制时会引发临床感染。本研究强调了可导致皮下感染的真菌的多样性。虽然这里记录的大多数微生物引起的是偶发性感染,但在我们的检索中,有几个属([具体属名])的检出频率更高,这表明它们具有促进皮下感染的毒力因子和/或栖息于使其更易通过创伤接种的自然生态位。